• About us
• Contact

Advertisement

Product › Details

cancer vaccine

	Next higher product group	cancer drug

Record changed: 2023-08-08

Advertisement

More documents for cancer vaccine

• [1] CureVac N.V.. (8/17/23). "Press Release: CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update". Tübingen & Boston, MA....
• [2] InSphero AG. (1/19/23). "Press Release: Brenus Pharma and InSphero Receive €1.5 Million in Grants from the European EUROSTARS Fund". Lyon & Schlieren....
• [3] ErVaccine Technologies S.A.. (1/5/23). "Press Release: ErVaccine Closes a €4.5 Million Financing Round and Prepares to Start Clinical Trial with Its First Therapeutic Cancer Vaccine in 2023". Lyon....
• [4] BioNTech SE. (12/16/22). "Press Release: BioNTech Announces Plans for a Clinical Trial Hub in Taiwan for mRNA-based Cancer Immunotherapies as Part of Asia-Pacific Expansion". Mainz....
• [5] CimCure. (6/21/22). "Press Release: Cancer Vaccine Biotech CimCure Raises € 5 Million in Seed Round Investment Led by Positron Ventures"....
• [6] CureVac N.V.. (6/8/22). "Press Release: CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform". Tübingen & Amsterdam....
• [7] Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim....
• [8] Transgene S.A.. (2/10/22). "Press Release: Transgene Appoints Steven Bloom as Chief Business Officer". Strasbourg....
• [9] CureVac N.V.. (8/16/21). "Press Release: CureVac Announces Financial Results for the Second Quarter and First Half of 2021 and Provides Business Update". Tübingen, Boston, MA & London....
• [10] Targovax ASA. (3/7/22). "Press Release: Targovax ASA and Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted with QS-21 STIMULON". Oslo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.